ArticleClinicoEconomics and outcomes research : CEOR2018

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar.

Lee S Schwartzberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.